Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Proto Labs (PRLB) Asset Writedowns and Impairment (2022 - 2025)

Proto Labs (PRLB) has disclosed Asset Writedowns and Impairment for 5 consecutive years, with -$448000.0 as the latest value for Q4 2025.

Quarterly Asset Writedowns and Impairment changed N/A to -$448000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $448000.0 through Sep 2025, up 75.0% year-over-year, with the annual reading at $256000.0 for FY2024, N/A changed from the prior year.
Asset Writedowns and Impairment hit -$448000.0 in Q4 2025 for Proto Labs, down from $229000.0 in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $1.0 million in Q3 2022 to a low of -$2.8 million in Q4 2022.
Historically, Asset Writedowns and Impairment has averaged -$256000.0 across 3 years, with a median of $224000.0 in 2025.